< (From left) Dr. Ju-Gyeong Kang, Ph.D candidate TaeJun Seol, Professor Dae-Sik Lim >
Metabolic diseases such as obesity, fatty liver, and insulin resistance are rapidly increasing worldwide, but fundamental methods to regulate the process of fat formation remain limited. In particular, once adipocytes (fat cells) are formed, they are difficult to reduce, making treatment challenging. Amidst this, a research team from our university has discovered the existence of a 'switch' that prevents fat formation. This discovery elucidates how an 'epigenetic switch'—which regulates gene activity without altering the DNA sequence itself—functions during the process of adipogenesis, presenting new possibilities for the precise control of obesity and metabolic diseases in the future.
The research team, led by Professor Dae-Sik Lim and Professor Ju-Gyeong Kang from KAIST's Department of Biological Sciences, announced on January 25th that they have identified 'YAP/TAZ,' key regulators of the Hippo signaling pathway*, as playing the role of an 'epigenetic differentiation inhibition switch' during the process of adipocyte differentiation**. The team proposed a new mechanism in which YAP/TAZ extensively inhibits the activation of genes responsible for adipocyte formation through its downstream target, 'VGLL3.' *Hippo signaling pathway: A cellular control system that regulates when cells grow, stop dividing, and differentiate. **Adipocyte differentiation: The process by which preadipocytes (or stem cells) transform into mature adipocytes.
Cell differentiation is not a simple matter of a single gene turning on or off; it is a complex, organic process involving multiple genes and DNA regulatory regions. The research team tracked the entire process of preadipocytes* differentiating into adipocytes using Next-Generation Sequencing (NGS), which allows for the simultaneous analysis of gene expression changes and epigenetic modifications. *Preadipocyte: A developing intermediate-stage cell whose direction as to which cell it will become has already been determined.
As a result, they confirmed that under conditions where YAP/TAZ is activated, the genetic program that establishes adipocyte identity fails to operate, and the overall adipocyte differentiation network—centered around PPARγ*—is suppressed. *PPARγ: The 'metabolic master switch' regulator that controls energy storage and utilization in the body.
Specifically, through single-cell analysis of adipose tissue, the research team identified VGLL3 as a novel target gene of YAP/TAZ. While it was previously known that YAP/TAZ directly binds to and inhibits PPARγ, this study revealed that VGLL3 indirectly controls the entire adipocyte differentiation program by suppressing 'enhancers,' which are the DNA regulatory regions of adipocyte genes. This signifies that the Hippo signaling pathway plays a crucial role in regulating the core timing that determines when and how robustly fat cells are created.
Dysfunction of adipose tissue is deeply linked to various metabolic diseases such as obesity, insulin resistance, and fatty liver. The research team expects that further studies on how the YAP/TAZ–VGLL3–PPARγ axis regulatory principle involves adipocyte formation and functional abnormalities will provide new clues for regulating or treating metabolic diseases.
< Schematic Diagram of Adipocyte Gene Regulation >
Professor Dae-Sik Lim stated, "This study is the first to establish that adipocyte differentiation is precisely controlled at the epigenetic level, beyond simple gene regulation. It has laid an important foundation for a more sophisticated understanding of the mechanisms behind adipocyte identity changes and, in the long term, for developing personalized treatment strategies for patients with metabolic diseases."
This research, with Ph.D. student TaeJun Seol and Dr. Ju-Gyeong Kang as co-first authors, was published on January 14th in the world-renowned international academic journal, Science Advances. ※ Paper Title: YAP/TAZ-VGLL3 governs adipocyte fate via epigenetic reprogramming of PPARγ and its target enhancers, DOI: 10.1126/sciadv.aea7235
Meanwhile, this research was conducted with support from the Leader Researcher Support Program and the Overseas Excellent Scientist Recruitment Program of the National Research Foundation of Korea, funded by the Ministry of Science and ICT.
